ABSTRACT
Despite the significant advances that have been made during the last several decades, much remains to be learned about pharmacotherapy and talk therapy treatments for major depressive disorder (MDD). We stand at a point of potentially massive change in our understanding of what are the most effective tools in our psychotherapeutic and pharmacotherapeutic armamentarium, and what are the most effective ways to utilize these tools. Several domains that represent the most promising and compelling areas of MDD-focused research are highlighted in the following section.
